Cryder Capital Partners’s Parexel International Corp PRXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-196,334
Closed -$12.4M 12
2017
Q1
$12.4M Hold
196,334
5.04% 11
2016
Q4
$12.9M Buy
196,334
+16,128
+9% +$1.01M 5.76% 11
2016
Q3
$12.5M Buy
180,206
+31,300
+21% +$2.11M 7.34% 9
2016
Q2
$9.36M Buy
148,906
+26,533
+22% +$1.64M 7.51% 8
2016
Q1
$7.68M Buy
122,373
+9,124
+8% +$563K 5.87% 10
2015
Q4
$7.71M Sell
113,249
-6,036
-5% -$393K 6.48% 7
2015
Q3
$7.39M Buy
119,285
+13,495
+13% +$908K 4.77% 12
2015
Q2
$6.8M Sell
105,790
-5,635
-5% -$380K 4.93% 12
2015
Q1
$7.69M Sell
111,425
-6,240
-5% -$398K 5.41% 9
2014
Q4
$6.54M Buy
+117,665
New +$6.79M 4.93% 11

Other funds holding PRXL

Cryder Capital Partners's PRXL Position: Q2 2017 in Review

Cryder Capital Partners sold out of Parexel International Corp (PRXL) in Q2 2017, closing a stake of 196,334 shares — an estimated $12.4M sold.

Cryder Capital Partners first reported a position in PRXL in Q4 2014 and held it in 10 quarters. The position peaked at $12.9M in Q4 2016. 311 funds tracked by Wall St. Rank hold PRXL as of Q2 2017.

  • Cryder Capital Partners reported no remaining Parexel International Corp position as of Q2 2017 after selling out during the quarter.
  • Cryder Capital Partners sold 196,334 Parexel International Corp shares in Q2 2017, an estimated $12.4M.
  • Cryder Capital Partners first reported a position in Parexel International Corp in Q4 2014 and held it in 10 quarters.
  • Cryder Capital Partners's Parexel International Corp position peaked at $12.9M in Q4 2016.
  • 311 funds tracked by Wall St. Rank held Parexel International Corp as of Q2 2017.

Based on Cryder Capital Partners's 13F filing for Q2 2017, filed 27 Jul 2017.